Only in Titles

           Search results for: Biological Fluids: Normal Human Semen Pooled   


#9518873   1998/04/03 Save this To Up

Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin.

Recent studies have found follistatin to be an important regulator of activin bioactivity. Whilst a number of assay formats have been described, all are of limited sensitivity and require the use of isotopes. Many use polyclonal antibodies. Furthermore, a wide range of follistatin preparations have been used as standards, complicating inter-laboratory comparison. We now describe an ultra-sensitive two-site enzyme immunoassay using a pair of mouse monoclonal antibodies raised against follistatin 288. The presence of sodium deoxycholate and Tween 20 in the diluent gave results for total (free and activin-dissociated) follistatin. The assay had a detection limit of <19 pg/ml and recovery of spiked follistatin 288 from amniotic fluid, serum seminal plasma, human follicular fluid and granulosa cell conditioned medium averaged 100.7 +/- 7.5%, 89.1 +/- 5.5%, 98 +/- 4.9%, 96 +/- 7.2% and 123.9 +/- 11% respectively. The intra- and interplate coefficients of variation were < 5%. An excess of activin-A (50 ng/ml) prior to assay did not affect follistatin recovery. Inhibin-A, inhibin-B, activin-A, activin-B and activin-AB had minimal cross-reactivity (<0.3%). However, follistatin 315 had a significant cross-reaction (9.9%). Serially diluted human samples gave dose-response curves parallel to the standard. Pooled human follicular fluid contained high concentrations of follistatin (approximately 242 ng/ml). Follistatin was also found in maternal serum during pregnancy (first trimester approximately 0.8 ng/ml, third trimester approximately 2.8 ng/ml), normal male serum (approximately 0.45 ng/ml), amniotic fluid (sixteen week approximately 3.63 ng/ml, term approximately 0.89 ng/ml), seminal plasma (2.4-30 ng/ml) and human granulosa cell conditioned media (approximately 0.44 ng/ml). Serial serum samples taken throughout the menstrual cycle of ten women showed fluctuating follistatin concentrations (approximately 0.62 ng/ml) with no apparent relationship to the stage of the cycle. Interestingly, pooled serum from postmenopausal women appeared to have higher follistatin levels than any of the normal women (approximately 1.4 ng/ml). The possible presence in certain samples of mixtures of follistatin isoforms with different immunoreactivities poses major problems of interpretation in this and all other current follistatin immunoassays. Further work is needed to identify the major immunoreactive forms in different tissues and fluids. Nevertheless, the new assay has a number of advantages over previous assays and should prove a useful tool for various clinical and physiological studies.

2200 related Products with: Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin.

Leptin ELISA Kit, Human A succinate-CoA ligase, GDP formin-like 1 antibody So succinate-CoA ligase, ADP MOUSE ANTI HUMAN CD15, Pr MOUSE ANTI HUMAN CD19 RPE MOUSE ANTI HUMAN CD15, Pr MOUSE ANTI BOVINE ROTAVIR NFκB-p65(Phospho-Thr435) HNF4α (Phospho-Ser304) A Ephrin-B2 (Phospho-Tyr316 Ephrin-B2 (Phospho-Tyr330

Related Pathways


#6793300   1981/12/15 Save this To Up

Effect of steroid hormones on the metabolism of human spermatozoa.

Information relating to the effect of steroids on the metabolism and motility of human spermatozoa is limited despite the increasing interest in the use of these hormones for the purpose of contraception. In the present study it was shown that progesterone, testosterone, and 11-beta-OH-progesterone significantly inhibit the CO2 production of human spermatozoa. Estrone was ineffective. Progesterone and testosterone, but not estrone, also significantly depressed O2 uptake. In contrast to CO2 production and O2 uptake, lactic acid production was not significantly affected by any of the steroids studied. The inability of estrone to inhibit sperm metabolism was not due to its lower solubility relative to the other steroids tested. The data indicate that the effective steroids inhibit sperm respiration, but not the sperm glycolytic pathway.

2375 related Products with: Effect of steroid hormones on the metabolism of human spermatozoa.

TCP-1 theta antibody Sour steroidogenic acute regul Recombinant Human Oncosta Recombinant Human PKC the Recombinant Human PKC the Recombinant Human PKC the RAP2C, member of RAS onco Oncostatin M, human recom Oncostatin M, human recom Mouse anti human Oncostat Ofloxacin CAS Number [824 Human Bone Metabolism Ar

Related Pathways